Manning & Napier Advisors’s Amgen AMGN Stock Holding History

Manning & Napier Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63.2K	Buy	181 +84	+87%	+$29.9K	﹤0.01%	354
2025 Q4	$31.9K	Buy	97 +32	+49%	+$10.2K	﹤0.01%	347
2025 Q3	$18.3K	Buy	+65	New	+$18.9K	﹤0.01%	377
2017 Q3	$21.4M	Sell	114,745 -425	-0.4%	-$75.3K	0.18%	87
2017 Q2	$19.8M	Buy	115,170 +40,789	+55%	+$6.63M	0.17%	85
2017 Q1	$12.2M	Buy	74,381 +3,378	+5%	+$561K	0.09%	93
2016 Q4	$10.4M	Buy	71,003 +2,508	+4%	+$377K	0.07%	118
2016 Q3	$11.4M	Sell	68,495 -1,263	-2%	-$214K	0.07%	109
2016 Q2	$10.6M	Buy	+69,758	New	+$10.8M	0.06%	115
2013 Q4	–	Sell	-5,241	Closed	-$586K	–	335
2013 Q3	$586K	Sell	5,241 -123,656	-96%	-$13.4M	﹤0.01%	313
2013 Q2	$12.7M	Buy	+128,897	New	+$13.4M	0.07%	134

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Manning & Napier Advisors's AMGN Position: Q1 2026 in Review

Manning & Napier Advisors increased its Amgen (AMGN) stake by 87% in Q1 2026, buying an estimated $29.9K and bringing the position to 181 shares worth $63.2K. The position accounts for ﹤0.01% of the portfolio, ranked #354.

Manning & Napier Advisors first reported a position in AMGN in Q2 2013 and has held it in 11 quarters since. The position peaked at $21.4M in Q3 2017. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Manning & Napier Advisors held 181 shares of Amgen worth $63.2K as of Q1 2026.
Manning & Napier Advisors bought 84 Amgen shares in Q1 2026, an estimated $29.9K.
Amgen made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q1 2026, its #354 holding.
Manning & Napier Advisors first reported a position in Amgen in Q2 2013 and has held it in 11 quarters since.
Manning & Napier Advisors's Amgen position peaked at $21.4M in Q3 2017.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.